Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa

被引：0
|
作者：
Daniel Tobias Michaeli
Sophia Stoycheva
Simon Mashudu Marcus
Wenjia Zhang
Julia Caroline Michaeli
Thomas Michaeli
机构：
[1] Heidelberg University,Fifth Department of Medicine, University Hospital Mannheim
[2] Heidelberg University,Department of Personalized Oncology, University Hospital Mannheim
[3] London School of Economics and Political Science,Department of Health Policy
[4] Pfizer Inc,Health Economics and Outcomes Research
[5] Homerton University Hospital NHS Trust,Department of Obstetrics and Gynecology
[6] Asklepios-Clinic Hamburg-Altona,Division of Personalized Medical Oncology
[7] Asklepios Hospital Group,Department of Family Medicine and Primary Care, School of Clinical Medicine, Faculty of Health Science
[8] German Cancer Research Center (DKFZ),undefined
[9] University of the Witwatersrand,undefined
来源：
Clinical Drug Investigation | 2022年 / 42卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：333 / 343
页数：10
相关论文
共 50 条
  • [21] ADDITION OF BIVALENT OR QUADRIVALENT HPV VACCINES TO CERVICAL CANCER SCREENING, IN COLOMBIA. A COST-EFFECTIVENESS ANALYSIS
    Aponte, J.
    Eslava-Schmalbach, J.
    Gamboa, O.
    Fajardo, L.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A219 - A219
  • [22] Potential health impact and cost-effectiveness of bivalent human papillomavirus (HPV) vaccination in Afghanistan
    Anwari, Palwasha
    Debellut, Frederic
    Vodicka, Elisabeth
    Clark, Andrew
    Farewar, Farhad
    Zhwak, Zubiada A.
    Nazary, Dastagger
    Pecenka, Clint
    LaMontagne, D. Scott
    Safi, Najibullah
    [J]. VACCINE, 2020, 38 (06) : 1352 - 1362
  • [23] Cost-effectiveness of HPV vaccination in Belize
    Walwyn, Leslie
    Janusz, Cara Bess
    Clark, Andrew David
    Prieto, Elise
    Waight, Eufemia
    Largaespada, Natalia
    [J]. VACCINE, 2015, 33 : A174 - A181
  • [24] Nonavalent HPV vaccine's cost-effectiveness for Norway remains to be determined
    Goodman, Elizabeth
    Daniels, Vincent
    Rauscher, Andreas
    Stanley, Margaret
    [J]. PREVENTIVE MEDICINE, 2021, 150
  • [25] Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United States
    Chesson, Harrell W.
    Meites, Elissa
    Ekwueme, Donatus U.
    Saraiya, Mona
    Markowitz, Lauri E.
    [J]. VACCINE, 2018, 36 (29) : 4362 - 4368
  • [26] Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines
    Van Damme, Pierre
    Bonanni, Paolo
    Bosch, F. Xavier
    Joura, Elmar
    Kjaer, Susanne Krueger
    Meijer, Chris J. L. M.
    Petry, Karl-Ulrich
    Soubeyrand, Benoit
    Verstraeten, Thomas
    Stanley, Margaret
    [J]. VACCINE, 2016, 34 (06) : 757 - 761
  • [27] Estimating the epidemiological impact and cost-effectiveness profile of a nonavalent HPV vaccine in Spain
    De La Fuente, Jesus
    Hernandez Aguado, Juan Jose
    San Martin, Maria
    Ramirez Boix, Paula
    Cedillo Gomez, Sergio
    Lopez, Noelia
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (7-8) : 1949 - 1961
  • [28] COST-EFFECTIVENESS ANALYSIS OF HPV VACCINATION IN SLOVENIA
    Obradovic, M.
    Mrhar, A.
    Kos, M.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A272 - A272
  • [29] COST-EFFECTIVENESS OF SEASONAL VACCINATION WITH QUADRIVALENT INFLUENZA VACCINE IN PORTUGAL
    Almeida, J.
    Ferreira, C.
    Monteiro, S.
    [J]. VALUE IN HEALTH, 2019, 22 : S651 - S651
  • [30] The Case for Adolescent HIV Vaccination in South Africa A Cost-Effectiveness Analysis
    Moodley, Nishila
    Gray, Glenda
    Bertram, Melanie
    [J]. MEDICINE, 2016, 95 (04)
12345